LABGEN revenue for the last year amounted to 73.40 B KRW, the most of which — 42.12 B KRW — came from its highest performing source at the moment, Molecular Diagnostic Test Service, the year earlier bringing 88.88 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought LABGEN 50.39 B KRW, and the year before that — 129.30 B KRW.